Gatifloxacin, gemifloxacin, and moxifloxacin: The role of 3 newer fluoroquinolonesSARAVOLATZ, Louis D; LEGGETT, James.Clinical infectious diseases. 2003, Vol 37, Num 9, pp 1210-1215, issn 1058-4838, 6 p.Article

In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA)SARAVOLATZ, Louis D; PAWLAK, Joan; JOHNSON, Leonard B et al.SARAVOLATZ, Louis D; International journal of antimicrobial agents (Print). 2010, Vol 36, Num 5, pp 478-480, issn 0924-8579, 3 p.Article

Comparison of BACTEC^™ plus Aerobic/F and VersaTREK REDOX^® blood culture media for the recovery of Staphylococcus aureus from patients with suspected persistent bacteremiaBONILLA, Hector; ZERVOS, Mark; SARAVOLATZ, Louis D et al.The Journal of infection. 2011, Vol 63, Num 1, pp 89-90, issn 0163-4453, 2 p.Article

Comparative activity of telavancin against isolates of community-associated methicillin-resistant Staphylococcus aureusSARAVOLATZ, Louis D; PAWLAK, Joan; JOHNSON, Leonard B et al.Journal of antimicrobial chemotherapy (Print). 2007, Vol 60, Num 2, pp 406-409, issn 0305-7453, 4 p.Article

The Quad Pill, a Once-Daily Combination Therapy for HIV InfectionJOHNSON, Leonard B; SARAVOLATZ, Louis D.Clinical infectious diseases. 2014, Vol 58, Num 1, pp 93-98, issn 1058-4838, 6 p.Article

Etravirine, a Next-Generation Nonnucleoside Reverse-Transcriptase InhbitorJOHNSON, Leonard B; SARAVOLATZ, Louis D.Clinical infectious diseases. 2009, Vol 48, Num 8, pp 1123-1128, issn 1058-4838, 6 p.Article

A web-based course on infection control for physicians in training : An educational interventionFAKIH, Mohamad G; ENAYET, Iram; MINNICK, Steven et al.Infection control and hospital epidemiology. 2006, Vol 27, Num 7, pp 704-708, issn 0899-823X, 5 p.Article

Broad-range bacterial polymerase chain reaction for early detection of bacterial meningitisSARAVOLATZ, Louis D; MANZOR, Odette; VANDERVELDE, Nancy et al.Clinical infectious diseases. 2003, Vol 36, Num 1, pp 40-45, issn 1058-4838, 6 p.Article

Clinical and laboratory features of community-associated methicillin-resistant Staphylococcus aureus : Is it really new?JOHNSON, Leonard B; SAEED, Sajjad; PAWLAK, Joan et al.Infection control and hospital epidemiology. 2006, Vol 27, Num 2, pp 133-138, issn 0899-823X, 6 p.Article

In Vitro Activity of Retapamulin against Staphylococcus aureus Resistant to Various Antimicrobial AgentsSARAVOLATZ, Louis D; PAWLAK, Joan; SARAVOLATZ, Stephanie N et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 9, pp 4547-4550, issn 0066-4804, 4 p.Article

Rapid diagnosis of septic arthritis using 16S rDNA PCR: a comparison of 3 methodsBONILLA, Hector; KEPLEY, Robert; PAWLAK, Joan et al.Diagnostic microbiology and infectious disease. 2011, Vol 69, Num 4, pp 390-395, issn 0732-8893, 6 p.Article

Epidemiology and clinical outcomes of infective endocarditis in hemodialysis patients. CommentaryKAMALAKANNAN, Desikan; RAMA MANOHARA PAI; JOHNSON, Leonard B et al.The Annals of thoracic surgery. 2007, Vol 83, Num 6, pp 2081-2086, issn 0003-4975, 6 p.Article

Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophilaTAN, James S; FILE, Thomas M; DIPERSIO, Joseph R et al.Clinical infectious diseases. 2001, Vol 32, Num 11, pp 1562-1566, issn 1058-4838Article

Sustained Improvements in Peripheral Venous Catheter Care in Non—Intensive Care Units: A Quasi-Experimental Controlled Study of Education and FeedbackFAKIH, Mohamad G; JONES, Karen; REY, Janice E et al.Infection control and hospital epidemiology. 2012, Vol 33, Num 5, pp 449-455, issn 0899-823X, 7 p.Article

Effect of Nurse-Led Multidisciplinary Rounds on Reducing the Unnecessary Use of Urinary Catheterization in Hospitalized Patients. CommentaryFAKIH, Mohamad G; DUEWEKE, Cathleen; LIPSKY, Benjamin A et al.Infection control and hospital epidemiology. 2008, Vol 29, Num 9, pp 815-822, issn 0899-823X, 8 p.Article

A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100-300 CD4⁺ T cellsDE BOER, Alberdina W; MARKOWITZ, Norman; LANE, H. Clifford et al.Clinical immunology (Orlando, Fla. Print). 2003, Vol 106, Num 3, pp 188-196, issn 1521-6616, 9 p.Article